If lymph node involvement is verified in the patient undergoing neoadjuvant therapy that is a possible candidate for targeted axillary dissection (TAD), a marker needs to be inserted while in the lymph node immediately after biopsy.This investigation or therapeutic intervention is highly valuable for individuals, is often suggested with no restrict